Tibet Rhodiola Pharmaceutical Holding Co (600211) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.030x

Based on the latest financial reports, Tibet Rhodiola Pharmaceutical Holding Co (600211) has a cash flow conversion efficiency ratio of 0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.09 Million ≈ $17.13 Million USD) by net assets (CN¥3.94 Billion ≈ $576.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tibet Rhodiola Pharmaceutical Holding Co - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Tibet Rhodiola Pharmaceutical Holding Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Tibet Rhodiola Pharmaceutical Holding Co balance sheet liabilities for a breakdown of total debt and financial obligations.

Tibet Rhodiola Pharmaceutical Holding Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Rhodiola Pharmaceutical Holding Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aecon Group Inc. TO:ARE	0.062x
Punjab & Sind Bank NSE:PSB	-0.177x
NCC AB (publ) ST:NCC-B	-0.008x
Suzhou Nanomicro Technology Co Ltd SHG:688690	0.014x
Syngene International Limited NSE:SYNGENE	-0.010x
Stolt-Nielsen Limited LSE:0OHK	0.058x
ChipMOS Technologies TW:8150	0.079x
Coty Inc NYSE:COTY	0.147x

Annual Cash Flow Conversion Efficiency for Tibet Rhodiola Pharmaceutical Holding Co (1999–2024)

The table below shows the annual cash flow conversion efficiency of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Tibet Rhodiola Pharmaceutical Holding Co.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.95 Billion ≈ $578.32 Million	CN¥994.79 Million ≈ $145.57 Million	0.252x	-21.53%
2023-12-31	CN¥3.37 Billion ≈ $493.67 Million	CN¥1.08 Billion ≈ $158.35 Million	0.321x	+16.10%
2022-12-31	CN¥3.03 Billion ≈ $443.50 Million	CN¥837.38 Million ≈ $122.53 Million	0.276x	+99.38%
2021-12-31	CN¥2.65 Billion ≈ $387.05 Million	CN¥366.53 Million ≈ $53.64 Million	0.139x	-16.23%
2020-12-31	CN¥2.59 Billion ≈ $378.76 Million	CN¥428.17 Million ≈ $62.65 Million	0.165x	-17.33%
2019-12-31	CN¥2.45 Billion ≈ $358.04 Million	CN¥489.59 Million ≈ $71.64 Million	0.200x	+56.16%
2018-12-31	CN¥2.26 Billion ≈ $330.29 Million	CN¥289.22 Million ≈ $42.32 Million	0.128x	+186.57%
2017-12-31	CN¥2.05 Billion ≈ $299.31 Million	CN¥91.46 Million ≈ $13.38 Million	0.045x	-88.24%
2016-12-31	CN¥658.19 Million ≈ $96.31 Million	CN¥250.21 Million ≈ $36.61 Million	0.380x	+37.92%
2015-12-31	CN¥485.90 Million ≈ $71.10 Million	CN¥133.93 Million ≈ $19.60 Million	0.276x	+180.74%
2014-12-31	CN¥414.18 Million ≈ $60.61 Million	CN¥-141.40 Million ≈ $-20.69 Million	-0.341x	-148.81%
2013-12-31	CN¥399.20 Million ≈ $58.42 Million	CN¥279.22 Million ≈ $40.86 Million	0.699x	+379.69%
2012-12-31	CN¥385.44 Million ≈ $56.40 Million	CN¥56.20 Million ≈ $8.22 Million	0.146x	+328.05%
2011-12-31	CN¥354.94 Million ≈ $51.94 Million	CN¥12.09 Million ≈ $1.77 Million	0.034x	+481.16%
2010-12-31	CN¥324.19 Million ≈ $47.44 Million	CN¥1.90 Million ≈ $278.05K	0.006x	-90.17%
2009-12-31	CN¥300.00 Million ≈ $43.90 Million	CN¥17.88 Million ≈ $2.62 Million	0.060x	-22.44%
2008-12-31	CN¥279.15 Million ≈ $40.85 Million	CN¥21.46 Million ≈ $3.14 Million	0.077x	+215.24%
2007-12-31	CN¥274.28 Million ≈ $40.14 Million	CN¥-18.30 Million ≈ $-2.68 Million	-0.067x	-178.61%
2006-12-31	CN¥396.34 Million ≈ $58.00 Million	CN¥33.63 Million ≈ $4.92 Million	0.085x	+76.37%
2005-12-31	CN¥393.25 Million ≈ $57.54 Million	CN¥18.92 Million ≈ $2.77 Million	0.048x	-22.12%
2004-12-31	CN¥435.51 Million ≈ $63.73 Million	CN¥26.90 Million ≈ $3.94 Million	0.062x	-44.44%
2003-12-31	CN¥424.53 Million ≈ $62.12 Million	CN¥47.20 Million ≈ $6.91 Million	0.111x	+41.76%
2002-12-31	CN¥418.85 Million ≈ $61.29 Million	CN¥32.85 Million ≈ $4.81 Million	0.078x	+106.06%
2001-12-31	CN¥406.50 Million ≈ $59.48 Million	CN¥15.47 Million ≈ $2.26 Million	0.038x	-25.49%
2000-12-31	CN¥402.35 Million ≈ $58.88 Million	CN¥20.55 Million ≈ $3.01 Million	0.051x	+786.04%
1999-12-31	CN¥389.71 Million ≈ $57.03 Million	CN¥2.25 Million ≈ $328.81K	0.006x	--

About Tibet Rhodiola Pharmaceutical Holding Co

SHG:600211 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.96 Billion

CN¥13.38 Billion CNY

Market Cap Rank

#6402 Global

#1444 in China

Share Price

CN¥41.50

Change (1 day)

+2.57%

52-Week Range

CN¥35.59 - CN¥56.43

All Time High

CN¥165.99